Detalhe da pesquisa
1.
Evaluation of genetic variants associated with the risk of thiopurine-related pancreatitis: a case control study from ENEIDA registry.
Dig Dis
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452742
2.
Biological treatment interruption in inflammatory bowel disease: Motivation and predictive factors.
Gastroenterol Hepatol
; 46(9): 671-681, 2023 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-36375696
3.
Thiopurine adherence: a high prevalence with low impact on UC outcomes.
Rev Esp Enferm Dig
; 114(2): 76-82, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33733802
4.
Clinical assessment of risk factors for infection in inflammatory bowel disease patients.
Int J Colorectal Dis
; 35(3): 491-500, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915983
5.
Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.
Dig Dis Sci
; 64(6): 1612-1621, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30604371
6.
Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?
Scand J Gastroenterol
; 53(9): 1079-1084, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30189153
7.
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients. / Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad de Crohn y Colitis Ulcerosa (ACCU) para el manejo de los aspectos psicológicos en la enfermedad inflamatoria intestinal.
Gastroenterol Hepatol
; 41(2): 118-127, 2018 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-29275001
8.
Disease severity and treatment requirements in familial inflammatory bowel disease.
Int J Colorectal Dis
; 32(8): 1197-1205, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28361220
9.
Invasive pulmonary aspergillosis in an immunocompromised patient with severe ulcerative colitis.
Rev Esp Enferm Dig
; 109(4): 316-317, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28229616
10.
Coloduodenal and enterocutaneous fistula in twins with Crohn´s disease.
Rev Esp Enferm Dig
; 109(4): 291, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28372453
11.
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study.
Clin Gastroenterol Hepatol
; 14(10): 1426-1432.e1, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317850
12.
IBD or strongyloidiasis?
Rev Esp Enferm Dig
; 108(8): 516-20, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26634698
13.
Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial.
Trials
; 24(1): 432, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365665
14.
Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre Study.
Biomedicines
; 10(9)2022 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36140230
15.
Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia.
J Clin Med
; 11(10)2022 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628914
16.
Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn's disease (ProtDilat study): an open-label, multicentre, randomised trial.
Lancet Gastroenterol Hepatol
; 7(4): 332-341, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065738
17.
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
J Clin Med
; 11(15)2022 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35956133
18.
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Inflamm Bowel Dis
; 28(11): 1725-1736, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35166347
19.
Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease.
World J Clin Cases
; 9(36): 11285-11299, 2021 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35071559
20.
Could HLA-DQ suggest why some patients have olmesartan-related diarrhea and others don't?
Am J Gastroenterol
; 110(10): 1507-8, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26465910